Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
New to Comunitee?

or Sign Up with Email


>> VERTEX Latest News

MAR 11, 2014 - Huffington Post

A Must Read - Share

Is This Hepatitis C Treatment Worth $1,000 A Pill?

WASHINGTON (AP) — An innovative hepatitis C drug that was only recently hailed as a breakthrough treatment is facing skepticism from some health care providers, as they consider whether it is worth the $1,000-a-pill price set by manufacturer Gilead Sciences Inc. A panel of California medical experts voted Monday that Gilead's Sovaldi represents a "low value" treatment, considering its cost compared with older drugs for the blood-borne virus. The vote was part of a broader review of new hepatitis C drugs by the California Technology Assessment Forum, an insurance industry-affiliated group ... Read More

Tags: Is This Hepatitis C Treatment Worth $1,000 A Pill?,  Vertex Latest News